DJIA 16,204.97 -211.61 -1.29%
NASDAQ 4,363.14 -146.42 -3.25%
S&P 500 1,880.05 -35.40 -1.85%
market minute promo

InterMune (NASDAQ: ITMN)

company name or ticker
Company Photos
(Click to zoom)

Today's Market: China Testing 52-Week Highs And M&A News/Rumors

Top Analyst Upgrades and Downgrades: Foot Locker, CBOE, InterMune, US Steel and More

InterMune Inc. Shareholders Can Now Breathe Easier Thanks to Roche

Roche stuns Wall Street and investors by snatching up InterMune and its first-in-class lung disease drug. But, does this deal make sense?

Benzinga's Weekend M&A Chatter

Roche Buying InterMune for $8.3 Billion

Stocks: 4 things to know before the open

Premarkets: 4 things to know before the open

Will This Analyst Downgrade Hurt InterMune (ITMN) Stock Today?

How Sanofi's Growth Strategy Will Catapult Afrezza Into a Blockbuster Drug

IWM, FXE: Big ETF Outflows

Today In SA PRO: Monday, August 18

See More Articles...